In partnership with

Hello 👋

Welcome back to another edition of Weekend Rounds!

One of us is on vacation this week, so the other one is driving the newsletter solo. If you notice fewer puns than usual, now you know who was responsible for them.

It's also the last weekend before Halloween, so a friendly heads-up to our ER colleagues: the chocolate calls are coming. Stock up on patience.

Here's what we're covering:

💊 Nearly 4,000 compounded meds recalled
🐱 Cats are up, puppies are way down
🩺 Your techs want more responsibility
🔄 Rounds Roundup

💊 Nearly 4,000 compounded meds recalled

If your phones haven't started ringing about this one yet, give it until Monday.

On October 21, Wedgewood Pharmacy announced a voluntary recall of compounded veterinary medications shipped across the U.S. between February 18 and October 6, 2026. The problem started in the company's own lab. Some of the testing data used to confirm potency wasn't reliable, so certain products may contain too little drug and others too much. According to dvm360, the recall covers nearly 4,000 product listings, and the list of dosage forms reads like a pharmacy catalogue: oral suspensions, injectables, eye and ear preparations, pastes, gels and topicals. Patients range from dogs and cats to horses, zoo animals and fish.

So far Wedgewood has received 98 complaints, seven of them classified as serious. Chief veterinary officer Dr. Rae Hutchins told AAHA that works out to roughly 0.04% of the affected prescriptions. That's a small number, but for the patient on the wrong end of it, low potency means a drug that quietly stops working and high potency means a possible overdose. This also isn't Wedgewood's first potency recall.

What to do this week:

  • Check your inventory against Wedgewood's recall lookup and quarantine anything that matches.

  • If you dispensed affected product, identify and notify those clients.

  • The recall line is 866-562-5931 (weekdays 8 a.m. to 9 p.m. ET, Saturdays 9 to 5).

Last week we wrote about pharmacists getting a veterinary specialty. A week like this is a pretty good argument for why that matters.

🐱 Cats are up, puppies are way down

Cats have quietly become the most dependable growth story in companion animal practice. CATalyst Council's latest feline market report, built on Vetsource data from 6,595 U.S. practices, shows feline visits up 2.7% in the third quarter compared with a year earlier, while visits across all species fell 1.9%. That's 12 straight quarters of growth, and cats now make up 24% of companion animal visits, up from 21% three years ago.

The puppy numbers are a different story. Puppy visits from July through September dropped 10% and are on pace to finish 44% below the pre-pandemic baseline of 2018 and 2019. Kitten visits slipped a little (0.9%) but are still tracking about 11% above that baseline.

Why should a slow puppy year worry you now? Because every dog stays in the population for life. A small puppy class today means fewer young adult dogs in three years and fewer seniors in ten. CATalyst's modelling has combined dog and cat visits shrinking 1% to 2% a year over the next decade.

The catch on the cat side is retention. CATalyst's household survey found 62% of cats arrive through informal routes (a stray, a garage litter, a coworker rehoming one), and plenty of owners treat the kitten series as the whole job.

Why it matters: That first kitten visit is your best shot at a 15-year patient. CATalyst's free Kitten in the Room guide suggests booking the next visit before they leave, pitching annual exams around catching hidden disease instead of "shots," and asking every client, dog people included, whether there's a cat at home.

Discover laptops with built-in intelligence.

Shift your workforce into hyper-productivity mode with Dell Pro laptops powered by Intel® Core™ Ultra with Intel vPro®. Shop on Dell Premier.

🩺 Your techs want more responsibility

National Veterinary Technician Week wrapped up yesterday, so the timing on this one is hard to beat. (Did you buy your techs that coffee?)

A new report from Penn Foster and The Harris Poll surveyed 206 U.S. veterinary technicians and 509 pet owners in June. Most techs said they're qualified to independently handle vaccines and follow-ups (80%), routine wellness exams (78%) and client education and care plans (69%). More than half of credentialed techs (55%) said their clinical skills are underused, and 71% support a tiered model that includes tech-led visits.

Pet owners seem open to the idea. About two in three said they've booked, or would book, an appointment directly with a credentialed tech. Meanwhile, 36% had delayed or skipped care, and 28% had waited three weeks or more for an appointment or couldn't get one at all.

So what's holding practices back? According to techs, mostly the practice itself. The top barriers were a culture that sees techs as assistants (44%), clinic policies (42%) and how comfortable vets are handing work off (38%).

Our take: Consider the source. Penn Foster sells veterinary technology education, so this conclusion suits them, and what a tech can legally do without a vet varies a lot by state and province. Even so, it lines up with the AVMA practice data we covered last week. The biggest profit centres all run through a veterinarian, so freeing up doctor time is the lever, and your techs are the cheapest way to pull it.

🍁 For our Canadian readers: October is also RVT Month in Canada, so you've still got a week to show your RVTs some love.

🔄 Rounds Roundup

What else happened this week? Here are the other stories that caught our eye:

Big pet food goes fresh: Hill's and Royal Canin have both launched refrigerated or frozen dog food, including Royal Canin's first fresh therapeutic diets (sold through vet clinics for now). Expect questions, especially since "fresh" still has no official AAFCO definition.

Pet supplement labels leave a lot out: an industry review of 56 brands found 61% of product pages didn't say how much of each active ingredient is in a serving, and 99% had no published trial on the finished product. The review came from a supplement company, but AVMA's checklist at the end is handy for client conversations.

Bonded clients are better clients: a new HABRI survey found owners widely recognize the health benefits of having a pet, and the ones with the strongest bonds were more likely to see their vet regularly and keep vaccines current.

FDA approves a ready-to-use Convenia for dogs: twice the concentration of the original (160 mg/mL), with up to 14 days of coverage from one injection. Dogs only, since two inactive ingredients may be toxic to cats. Maybe tape a note to the fridge.

Raccoon rabies keeps spreading in Quebec: the province has confirmed a third infected cat, and both the owner and a veterinarian were treated after exposure. Université de Montréal's vet school is running $15 pet rabies vaccine clinics through late November.

Maryland's first vet school clears a major hurdle: the University of Maryland Eastern Shore received a letter of reasonable assurance from the AVMA Council on Education and plans to welcome its first DVM class in summer 2027. It will be the first veterinary school at a public HBCU.

New AAHA parasitology guidelines land October 29: the 2026 One Health guidelines cover emerging parasite threats in dogs and cats, and they were co-chaired by Dr. Jason Stull of the Atlantic Veterinary College at UPEI. Canadian content, be still our northern hearts.

How an alpaca is helping fight the vet shortage: students in a Renton, Washington, training program provide vaccines, dental work and routine care to animals that might otherwise go without. The alpaca's exact role is unclear to us, but we support it.

How did we do today?

Tell us what you thought of this edition of Weekend Rounds so we can keep improving!

Login or Subscribe to participate